SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced today that the company was selected and is scheduled to present at the 2010 BIO Business Forum during the BIO International Convention in Chicago (May 3-6, 2010). Nuon will provide a corporate overview including an update on its phase 2 program in rheumatoid arthritis (RA) and progress with advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. The presentation will be held on Thursday, May 6, 2010 at 10:45 AM Central time in Room 2 of McCormick Place.
